Bellete Ambaw 4
4 · CG Oncology, Inc. · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Bellete Ambaw
President and COO
Transactions
- Award
Stock Option (Right to Buy)
2024-10-04+175,500→ 175,500 totalExercise: $36.63Exp: 2034-10-03→ Common Stock (175,500 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.